THORACIC CANCER
Clinical trials for THORACIC CANCER explained in plain language.
Never miss a new study
Get alerted when new THORACIC CANCER trials appear
Sign up with your email to follow new studies for THORACIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Foot massage may ease chemo sickness in cancer patients
Symptom relief CompletedThis study looked at whether foot reflexology—a type of foot massage—can reduce nausea and vomiting caused by platinum-based chemotherapy. Eighty people with lung or digestive cancer received reflexology sessions during their chemo infusions and were asked to do self-massage betw…
Matched conditions: THORACIC CANCER
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New phone therapy aims to ease anxiety in older cancer patients
Symptom relief CompletedThis study tested a telephone-based therapy called Managing Anxiety from Cancer (MAC) for older adults (65+) with cancer and their caregivers. The therapy includes seven sessions covering relaxation, communication, and problem-solving skills. The goal was to see if it reduces anx…
Matched conditions: THORACIC CANCER
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New scanner aims to sharpen cancer radiation targeting
Knowledge-focused CompletedThis study tested a new on-couch imaging system called HyperSight, which takes 3D X-ray pictures (CBCT) of cancer patients right before their radiation treatment. 46 adults with head/neck, chest, abdomen, or pelvic cancers received both the new HyperSight scan and a standard scan…
Matched conditions: THORACIC CANCER
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Scientists track Body's reaction to cancer immunotherapy
Knowledge-focused CompletedThis study looked at 98 adults with cancers like melanoma and lung cancer who were starting immunotherapy. Researchers measured inflammatory markers in their blood to understand how the body reacts to these drugs. The goal was to find ways to better manage side effects from treat…
Matched conditions: THORACIC CANCER
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC